The concern of generic rivalry has long loomed over copyright’s iconic drug, Viagra, sparking questions about the outlook of related drug investments. While first periods saw significant returns, the patent expiration has opened the door for less expensive alternatives, potentially lowering profitability and creating a significant risk for invest